Evidence map›Paper›PMID 36116137›Full record

ArticleClinical and translational medicine2022

Integrative analysis identifies three molecular subsets in ovarian cancer.

Bo Liu, Xinchan Ji, Jinmeng Li, Nian Zhu, Junqi Long, Xujie Zhuang, Huina Wang, Lujia Li, Yuhaoran Chen, Shuangtao Zhao

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bo LiuSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing, 100124, China.
Xinchan JiSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing, 100124, China.ORCID 0000-0001-9300-2571
Jinmeng LiSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing, 100124, China.ORCID 0000-0002-7613-9506
Nian ZhuSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing, 100124, China.ORCID 0000-0002-3722-1806
Junqi LongSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing, 100124, China.
Xujie ZhuangSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing, 100124, China.ORCID 0000-0002-4514-8741
Huina WangSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing, 100124, China.
Lujia LiSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing, 100124, China.
Yuhaoran ChenSchool of Software Engineering, Faculty of Information Technology, Beijing University of Technology, Beijing, 100124, China.
Shuangtao ZhaoDepartment of Thoracic Surgery, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China.ORCID 0000-0002-8624-7834

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ovarian NeoplasmsCarcinoma, Ovarian EpithelialFemaleHumans

Identifiers

PMID36116137
PMCPMC9482804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.